J.W. Cole Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $585K | Sell |
4,623
-119
| -3% | -$15.1K | 0.01% | 864 |
|
|
2025
Q1 | $607K | Buy |
4,742
+1,641
| +53% | +$210K | 0.02% | 709 |
|
|
2024
Q4 | $410K | Sell |
3,101
-173
| -5% | -$22.9K | 0.02% | 674 |
|
|
2024
Q3 | $477K | Buy |
3,274
+31
| +1% | +$4.51K | 0.02% | 612 |
|
|
2024
Q2 | $445K | Sell |
3,243
-2,902
| -47% | -$398K | 0.02% | 551 |
|
|
2024
Q1 | $843K | Sell |
6,145
-441
| -7% | -$60.5K | 0.04% | 378 |
|
|
2023
Q4 | $895K | Sell |
6,586
-220
| -3% | -$29.9K | 0.05% | 324 |
|
|
2023
Q3 | $832K | Sell |
6,806
-101
| -1% | -$12.4K | 0.06% | 291 |
|
|
2023
Q2 | $877K | Sell |
6,907
-38
| -0.5% | -$4.82K | 0.06% | 291 |
|
|
2023
Q1 | $897K | Buy |
6,945
+675
| +11% | +$87.2K | 0.06% | 311 |
|
|
2022
Q4 | $823K | Sell |
6,270
-2,114
| -25% | -$278K | 0.06% | 307 |
|
|
2022
Q3 | $981K | Sell |
8,384
-411
| -5% | -$48.1K | 0.08% | 256 |
|
|
2022
Q2 | $1.04M | Buy |
8,795
+1,600
| +22% | +$188K | 0.08% | 257 |
|
|
2022
Q1 | $937K | Buy |
7,195
+180
| +3% | +$23.4K | 0.06% | 294 |
|
|
2021
Q4 | $1.07M | Buy |
+7,015
| New | +$1.07M | 0.07% | 284 |
|
|
2021
Q3 | – | Sell |
-7,839
| Closed | -$1.28M | – | 567 |
|
|
2021
Q2 | $1.28M | Buy |
7,839
+1,342
| +21% | +$220K | 0.1% | 227 |
|
|
2021
Q1 | $978K | Sell |
6,497
-2,243
| -26% | -$338K | 0.09% | 240 |
|
|
2020
Q4 | $1.32M | Sell |
8,740
-3,373
| -28% | -$511K | 0.14% | 183 |
|
|
2020
Q3 | $1.64M | Buy |
12,113
+566
| +5% | +$76.6K | 0.13% | 177 |
|
|
2020
Q2 | $1.58M | Buy |
+11,547
| New | +$1.58M | 0.24% | 119 |
|
|
2020
Q1 | – | Sell |
-6,051
| Closed | -$729K | – | 279 |
|
|
2019
Q4 | $729K | Buy |
+6,051
| New | +$729K | 0.09% | 232 |
|